| Schedule of Financial Assets and Liabilities that are Measured at Fair Value on a Recurring Basis |
The Company’s fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | January 31, 2026 | | January 31, 2025 | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | | | | | | | | Cash equivalents(1) | | | | | | | | | | | | | | | | | Money market funds | $ | 1,407,062 | | | $ | — | | | $ | — | | | $ | 1,407,062 | | | $ | 1,470,040 | | | $ | — | | | $ | — | | | $ | 1,470,040 | | | U.S. Treasury securities | — | | | 598,398 | | | — | | | 598,398 | | | — | | | 2,490,097 | | | — | | | 2,490,097 | | | | | | | | | | | | | | | | | | | Other assets | | | | | | | | | | | | | | | | | Deferred compensation investments | 12,710 | | | — | | | — | | | 12,710 | | | 5,496 | | | — | | | — | | | 5,496 | | | Total assets | $ | 1,419,772 | | | $ | 598,398 | | | $ | — | | | $ | 2,018,170 | | | $ | 1,475,536 | | | $ | 2,490,097 | | | $ | — | | | $ | 3,965,633 | |
(1)Cash equivalents exclude $1.1 billion of time deposits, which are carried at cost and approximate fair value as of January 31, 2026.
|
| Schedule of Privately Held Equity Securities and Gains and Losses on Strategic Investments |
The Company’s investments in privately held securities as of January 31, 2026, consisted of the following (in thousands): | | | | | | | | | | | | | | | | | | | Privately held equity securities | | Privately held debt and other securities | | Total | | Initial total cost | $ | 75,007 | | | $ | — | | | $ | 75,007 | | | Cumulative net gains | 1,825 | | | — | | | 1,825 | | | Carrying amount, end of period | $ | 76,832 | | | $ | — | | | $ | 76,832 | |
The Company’s investments in privately held securities as of January 31, 2025, consisted of the following (in thousands): | | | | | | | | | | | | | | | | | | | Privately held equity securities | | Privately held debt and other securities | | Total | | Initial total cost | $ | 68,140 | | | $ | 1,000 | | | $ | 69,140 | | | Cumulative net gains | 3,404 | | | — | | | 3,404 | | | Carrying amount, end of period | $ | 71,544 | | | $ | 1,000 | | | $ | 72,544 | |
The components of gains and losses on strategic investments were as follows (in thousands): | | | | | | | | | | | | | | | | | | | Year Ended January 31, | | 2026 | | 2025 | | 2024 | | | | | | | | Unrealized losses recognized on privately held equity securities including impairment | $ | (1,579) | | | $ | (1,000) | | | $ | (1,459) | | | Unrealized losses | (1,579) | | | (1,000) | | | (1,459) | | | | | | | | | Realized gains recognized on sales of privately held equity securities | 4,161 | | | 6,975 | | | 3,936 | | | Realized losses recognized on sales of privately held equity securities | — | | | (654) | | | — | | | Realized gains, net | 4,161 | | | 6,321 | | | 3,936 | | | Gains on strategic investments, net | $ | 2,582 | | | $ | 5,321 | | | $ | 2,477 | | | | | | | | Unrealized losses recognized during the reporting period on privately held equity securities still held at the reporting date | $ | (1,579) | | | $ | (1,000) | | | $ | (1,459) | |
|